I lead Haystack Medical, where we are translating advanced microengineering into breakthrough clinical solutions for hearing loss and diagnostics.
Transitioning to First-in-Human (FIH) trials at Columbia NYP in NYC. Finalizing clinical protocols for inner-ear delivery.
Raising a $2.0M Seed Round. Currently $750k soft-circled with strategic angel and institutional interest.
Leveraging proprietary 2PTE-fabricated metallic microneedles to solve the "access challenge" of the Round Window Membrane.
If you are an investor or clinical partner interested in the future of otology, I’d love to connect.
aykut@haystackmedical.com